Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystalline Megestrol Acetate for CINV in Gastric Cancer
NCT07246070Phase 2Not yet recruiting
- Start
- Dec 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of megestrol in chemotherapy-induced nausea and vomiting (CINV). Planned start Dec 2025; status: not yet recruiting.
02
Drugs
megestrol
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07246070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07246070.